메뉴 건너뛰기




Volumn 50, Issue 4, 2011, Pages 503-505

Vulvar yolk sac tumor mixed with embryonal carcinoma in a peri-pubertal girl: A case report

Author keywords

Embryonal carcinoma; Peripheral blood stem cell transplantation; Vulvar mass; Yolk sac tumor

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; OXALIPLATIN; PACLITAXEL;

EID: 84855242448     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2011.10.018     Document Type: Article
Times cited : (6)

References (11)
  • 2
    • 33748787991 scopus 로고    scopus 로고
    • Primary yolk sac tumor (endodermal sinus tumor) of the vulva: case report and review of the literature
    • Basgul A., Gokaslan H., Kavak Z.N., Eren F.T., Bozkurt N. Primary yolk sac tumor (endodermal sinus tumor) of the vulva: case report and review of the literature. Eur J Gynaecol Oncol 2006, 27:395-398.
    • (2006) Eur J Gynaecol Oncol , vol.27 , pp. 395-398
    • Basgul, A.1    Gokaslan, H.2    Kavak, Z.N.3    Eren, F.T.4    Bozkurt, N.5
  • 3
    • 78650467479 scopus 로고    scopus 로고
    • Primary yolk sac (endodermal sinus) tumour of the vulva: a case report
    • Subrahmanya N.B., Kapadi S.N., Junaid T.A. Primary yolk sac (endodermal sinus) tumour of the vulva: a case report. Med Princ Pract 2011, 20:90-92.
    • (2011) Med Princ Pract , vol.20 , pp. 90-92
    • Subrahmanya, N.B.1    Kapadi, S.N.2    Junaid, T.A.3
  • 4
    • 37749003278 scopus 로고    scopus 로고
    • Primary endodermal sinus tumor of the vulva in a 52-year-old woman with long-term survival: a case report
    • Niwa K., Onogi K., Wu Y., Mori H., Tamaya T. Primary endodermal sinus tumor of the vulva in a 52-year-old woman with long-term survival: a case report. Eur J Gynaecol Oncol 2007, 28:506-508.
    • (2007) Eur J Gynaecol Oncol , vol.28 , pp. 506-508
    • Niwa, K.1    Onogi, K.2    Wu, Y.3    Mori, H.4    Tamaya, T.5
  • 6
    • 0034751441 scopus 로고    scopus 로고
    • Gynecologic tumors and symptoms in childhood and adolescence
    • Imai A., Furui T., Iida K., Tamaya T. Gynecologic tumors and symptoms in childhood and adolescence. Curr Opin Obstet Gynecol 2001, 13:469-473.
    • (2001) Curr Opin Obstet Gynecol , vol.13 , pp. 469-473
    • Imai, A.1    Furui, T.2    Iida, K.3    Tamaya, T.4
  • 7
    • 15544378665 scopus 로고    scopus 로고
    • Yolk sac tumor of the vulva: a case report with long-term disease-free survival
    • Khunamornpong S., Siriaunkgul S., Suprasert P., Chitapanarux I. Yolk sac tumor of the vulva: a case report with long-term disease-free survival. Gynecol Oncol 2005, 97:238-242.
    • (2005) Gynecol Oncol , vol.97 , pp. 238-242
    • Khunamornpong, S.1    Siriaunkgul, S.2    Suprasert, P.3    Chitapanarux, I.4
  • 8
    • 27244441799 scopus 로고    scopus 로고
    • Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
    • Kondagunta G.V., Bacik J., Donadio A., Bajorin D., Marion S., Sheinfeld J., et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 2005, 23:6549-6555.
    • (2005) J Clin Oncol , vol.23 , pp. 6549-6555
    • Kondagunta, G.V.1    Bacik, J.2    Donadio, A.3    Bajorin, D.4    Marion, S.5    Sheinfeld, J.6
  • 9
    • 23644441443 scopus 로고    scopus 로고
    • A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial
    • Mead G.M., Cullen M.H., Huddart R., Harper P., Rustin G.J., Cook P.A., et al. A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer 2005, 93:178-184.
    • (2005) Br J Cancer , vol.93 , pp. 178-184
    • Mead, G.M.1    Cullen, M.H.2    Huddart, R.3    Harper, P.4    Rustin, G.J.5    Cook, P.A.6
  • 10
    • 40549097353 scopus 로고    scopus 로고
    • Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
    • Kalykaki A., Papakotoulas P., Tsousis S., Boukovinas I., Kalbakis K., Vamvakas L., et al. Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). Anticancer Res 2008, 28:495-500.
    • (2008) Anticancer Res , vol.28 , pp. 495-500
    • Kalykaki, A.1    Papakotoulas, P.2    Tsousis, S.3    Boukovinas, I.4    Kalbakis, K.5    Vamvakas, L.6
  • 11
    • 78651399376 scopus 로고    scopus 로고
    • Gemox: a widely useful therapy against solid tumors - review and personal experience
    • Meriggi F., Zaniboni A. Gemox: a widely useful therapy against solid tumors - review and personal experience. J Chemother 2010, 22:298-303.
    • (2010) J Chemother , vol.22 , pp. 298-303
    • Meriggi, F.1    Zaniboni, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.